These results suggest that downregulation of miR-33b could trigger oncogenic properties through activation of the TAK1/FASN/CPT1A/NF-κB signaling axis and, as a consequence, facilitate peritoneal metastases of ovarian cancer. The gene discussed is CPT1A; the disease is ovarian carcinoma.